RIPE-KG · Version 1.1.0 · Resource
ripekg:publication-details/RIPEA4875E56C8C5C4ACF
https://w3id.org/ripe/ripe-kg/publication-details/RIPEA4875E56C8C5C4ACF
| Subject | Predicate | Object |
|---|---|---|
ripekg:evaluation/RIPEA4875E56C8C5C4ACF |
prov:used |
ripekg:publication-details/RIPEA4875E56C8C5C4ACFChanges in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
ripekg:publication-details/RIPEA4875E56C8C5C4ACFChanges in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
prism:endingPage |
361 |
ripekg:publication-details/RIPEA4875E56C8C5C4ACFChanges in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
prism:issn |
0003-4967 |
ripekg:publication-details/RIPEA4875E56C8C5C4ACFChanges in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
prism:publicationDate |
2014-12-30 |
ripekg:publication-details/RIPEA4875E56C8C5C4ACFChanges in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
prism:publicationName |
Annals of the Rheumatic Diseases |
ripekg:publication-details/RIPEA4875E56C8C5C4ACFChanges in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
prism:startingPage |
356 |
ripekg:publication-details/RIPEA4875E56C8C5C4ACFChanges in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
dcterms:publisher |
ripekg:publisher/RIPEP4BE129AB189EEF46Elsevier BV |
ripekg:publication-details/RIPEA4875E56C8C5C4ACFChanges in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
dcterms:title |
Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
ripekg:publication-details/RIPEA4875E56C8C5C4ACFChanges in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
rdf:type |
http://purl.org/spar/fabio/BibliographicMetadata |
ripekg:publication-details/RIPEA4875E56C8C5C4ACFChanges in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
rdf:type |
rdfs:Resource |
ripekg:publication-details/RIPEA4875E56C8C5C4ACFChanges in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
rdf:type |
owl:Thing |
ripekg:publication-details/RIPEA4875E56C8C5C4ACFChanges in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:publication-details/RIPEA4875E56C8C5C4ACFChanges in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
rdf:type |
ripe:PublicationDetailsPublication details |
ripekg:publication-details/RIPEA4875E56C8C5C4ACFChanges in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
rdf:type |
tido:Evidence |
ripekg:publication-details/RIPEA4875E56C8C5C4ACFChanges in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4875E56C8C5C4ACF |
ripekg:publication-details/RIPEA4875E56C8C5C4ACFChanges in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA4875E56C8C5C4ACF |
ripekg:publication-details/RIPEA4875E56C8C5C4ACFChanges in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
ripe:concerns |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
ripekg:publication-details/RIPEA4875E56C8C5C4ACFChanges in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA4875E56C8C5C4ACF-human-1-1 |
ripekg:publication-details/RIPEA4875E56C8C5C4ACFChanges in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA4875E56C8C5C4ACF-inspectai-1-1 |